Lundbeck
HLUN-B.CO
#2798
Rank
HK$47.76 B
Marketcap
HK$48.14
Share price
-2.55%
Change (1 day)
13.69%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): HK$4.78

According to Lundbeck's latest financial reports the company's current EPS (TTM) is HK$4.79. an increase over its 2024 EPS that were of HK$3.46.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025HK$3.9614.5%
2024HK$3.4629.29%
2023HK$2.6823.09%
2022HK$2.1737.26%
2021HK$1.58-84.61%
2020HK$10.29-24.61%
2019HK$13.65-42.06%
2018HK$23.5540.7%
2017HK$16.74146.26%
2016HK$6.80-120.48%
2015-HK$33.183231.32%
2014-HK$1.00-115.78%
2013HK$6.31-23.36%
2012HK$8.24-48.01%
2011HK$15.84-9.68%
2010HK$17.5413.72%
2009HK$15.4224.32%
2008HK$12.41-6.05%
2007HK$13.2181.77%
2006HK$7.27-16.76%
2005HK$8.73-17.58%
2004HK$10.59